Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.
BACKGROUND: Cotrimoxazole prophylaxis reduces morbidity and mortality in HIV-1-infected children, but mechanisms for these benefits are unclear. METHODS: CHAP was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected children in Zambia where background bacterial resista...
Những tác giả chính: | Mulenga, V, Ford, D, Walker, A, Mwenya, D, Mwansa, J, Sinyinza, F, Lishimpi, K, Nunn, A, Gillespie, S, Zumla, A, Chintu, C, Gibb, D |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2007
|
Những quyển sách tương tự
-
The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
Bằng: Walker, A, et al.
Được phát hành: (2007) -
Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in Zambia.
Bằng: Mwenya, D, et al.
Được phát hành: (2010) -
Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
Bằng: Walker, A, et al.
Được phát hành: (2006) -
Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.
Bằng: Walker, A, et al.
Được phát hành: (2009) -
Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
Bằng: Prendergast, A, et al.
Được phát hành: (2011)